INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Yale University
New Haven, Estados UnidosPublicaciones en colaboración con investigadores/as de Yale University (13)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
MIF is a common genetic determinant of COVID-19 symptomatic infection and severity
QJM : monthly journal of the Association of Physicians, Vol. 116, Núm. 3, pp. 205-212
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
2008
-
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma
Clinical Endocrinology, Vol. 68, Núm. 4, pp. 618-634
2002
-
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: A search for the early precursors of papillary cancer
American Journal of Pathology, Vol. 160, Núm. 6, pp. 2157-2167
-
RET activation and clinicopathologic features in poorly differentiated thyroid tumors
Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 1, pp. 370-379
2001
-
β-catenin dysregulation in thyroid neoplasms: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
American Journal of Pathology, Vol. 158, Núm. 3, pp. 987-996
1999
-
Downregulation of p27(KIP1) and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
American Journal of Surgical Pathology, Vol. 23, Núm. 6, pp. 678-685